2023-06-30 16:00:00
Medical devices: Carthera collects €37.5 million for its SonoCloud
During a series B round, the Parisian medtech Carthera announced that it had raised the sum of 37.5 million euros. This funding round was led by an investor “foreground”whose name has not been disclosed, alongside the European innovation council fund (EICF) and historical investors, such as Panakès Partners.
Thanks to this funding, the medtech intends to launch a multicenter pivotal clinical trial of its SonoCloud technology, in patients with recurrent glioblastoma multiforme (GBM). This device, implanted under the skin in the skull, opens the blood-brain barrier, using low-intensity ultrasound, to administer a chemotherapy agent (carboplatin). In the United States, SonoCloud has the designation Breaktrough Device from the FDA. In parallel, Carthera will continue to develop SonoCloud in the field of brain tumors and in neurodegenerative indications. “We have already treated more than 100 patients in Europe and the United States with the SonoCloud system, i.e. almost 500 therapeutic procedures. (…) We are convinced that the SonoCloud system can improve the therapeutic prospects of patients”said Alexandre Carpentier, the founder of Carthera.
I will tell you
source
Wacker to produce for Caeregen Therapeutics
Germany’s CDMO has announced that it will develop and produce CTR-107, a drug candidate from biotech Caeregen Therapeutics. This injectable treatment is positioned in the loss of vision due to pathologies of the retina, and more particularly, familial exudative vitreoretinopathy. Wacker Biotech will be in charge of the production of the active ingredient at its site in Halle, Germany, and the clinical batches will be manufactured at its site in Amsterdam, the Netherlands, to support the launch of a phase I/II in 2024.
Gleamer raises €27 million for its radiology solutions
Parisian medtech Gleamer raised 27 million euros in a series B financing round. With this sum, this young company will be able to move forward on its artificial intelligence (AI) solutions applied to radiography. The medtech wants to extend its portfolio to other technologies such as scanners and mammography. This new fundraising, following a seed round of €1.5 million in 2018 and a Series A round of €7.5 million in 2020, will also enable the company to work on its development in the future. internationally, in Europe but also in the United States. The financing round was led in particular by Supernova Invest.
Selected for you
1688191399
#short #Carthera #Wacker #Biotech #Gleamer